This compound is primarily utilized in research focused on combating SARS-CoV-2, the virus responsible for COVID-19. It has shown potential as an inhibitor, targeting specific viral mechanisms to prevent replication. Researchers are exploring its efficacy in reducing viral load and its potential use in developing antiviral therapies. Its application is largely confined to laboratory settings, where it is tested for its ability to block viral proteins or enzymes critical for the virus's lifecycle. Further studies aim to determine its suitability for clinical trials and eventual therapeutic use.